Literature DB >> 2435257

C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas.

G D Reynolds, R P Vance.   

Abstract

We examined immunohistochemically 104 formaldehyde-fixed, paraffin-embedded, human autopsy aortic specimens for C-reactive protein (CRP) presence and localization. In addition, we correlated immunoreactivity with a spectrum of the following histologic categories: normal aorta, fatty streak, atheromatous plaque, and fibrous plaque. Using appropriate controls, we confirmed CRP immunoreactivity in 3.3% of normal specimens, 75% of fatty streaks, 90.2% of atheromatous plaques, and 64.6% of fibrous plaques. Immunoreactivity in fatty streaks was located around collections of foam cells. Immunoreactivity in atheromatous plaques was in a bandlike distribution corresponding to the pale-staining insudative zone frequently seen in such lesions. The correlation and localization of CRP immunoreactivity in atherosclerotic lesions presented here suggests a functional role for CRP in the pathogenesis of atherosclerosis. Our results encourage efforts to determine more precisely the physiologic contributions of CRP to the development and exacerbation of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435257

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  36 in total

1.  C-reactive protein-mediated vascular injury requires complement.

Authors:  Fadi G Hage; Suzanne Oparil; Dongqi Xing; Yiu-Fai Chen; Mark A McCrory; Alexander J Szalai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-25       Impact factor: 8.311

2.  C-reactive protein and atherogenesis: new insights from established animal models.

Authors:  Jan Torzewski
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

3.  Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; David J Hammond; Antonio E Rusiñol; Lawrence A Potempa; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2009-06-21       Impact factor: 3.786

4.  Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.

Authors:  P T Johnson; K E Betts; M J Radeke; G S Hageman; D H Anderson; L V Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

Review 5.  The role of complement activation in atherosclerosis.

Authors:  Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  C-reactive protein/interleukin-6 ratio as marker of the size of the uncomplicated thoracic aortic aneurysms.

Authors:  Panagiotis Artemiou; Nicholas Charokopos; Efthymia Rouska; Frantisek Sabol; Ioannis Chrysogonidis; Vasiliki Tsavdaridou; Giannis Paschalidis
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-27

7.  Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin.

Authors:  Yu Asanuma; Annette Oeser; Eran Stanley; David G Bailey; Ayumi Shintani; C Michael Stein
Journal:  Arch Drug Inf       Date:  2008-07

8.  Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial disease.

Authors:  Joaquin De Haro; Francisco Acin; Francisco Jose Medina; Alfonso Lopez-Quintana; Jose Ramon March
Journal:  Clin Med Cardiol       Date:  2008-12-23

9.  Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

Authors:  Sanna Taskinen; Petri T Kovanen; Hanna Jarva; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 10.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.